Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United States
Pharma
Orzeyful gets off to races in US with 'lighter' DEA schedule
With a positive classification from the DEA paving the way for Orzeyful’s U.S. launch, Takeda is charting new territory in narcolepsy treatment.
Fraiser Kansteiner
Nov 12, 2026 11:16am
WuXi AppTec removed from US list of Chinese military companies
Nov 10, 2026 8:51am
Teva to shut down 'underutilized' New Jersey drug facility
Oct 27, 2026 4:17pm
WuXi AppTec has performed well in '26 despite US uncertainties
Oct 27, 2026 10:07am
COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia
Oct 23, 2026 8:42am
GSK pledges $800M to upgrade its R&D, manufacturing in PA
Oct 9, 2026 4:13pm
